GALP and obesity due to melanocortin 4 receptor deficiency: Experiments in obese mice have also demonstrated the anti-obesity effects of GALP, as continuous intracerebroventricular administration to ob/ob mice for 14 days results in a sustained decrease in food intake and body weight [82].